{"nct_id":"NCT03968419","title":"This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.","status":"TERMINATED","status_verified_date":"2024-06","start_date":"2019-11-05","start_date_type":"ACTUAL","primary_completion_date":"2022-04-20","primary_completion_date_type":"ACTUAL","completion_date":"2022-08-15","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}